Universities shun Europe's drug initiative.
作者信息
Gilbert Natasha
出版信息
Nature. 2010 Jul 15;466(7304):306-7. doi: 10.1038/466306b.
DOI:10.1038/466306b
PMID:20631770
Abstract
摘要
相似文献
1
Universities shun Europe's drug initiative.
Nature. 2010 Jul 15;466(7304):306-7. doi: 10.1038/466306b.
2
The innovative medicines initiative: a European response to the innovation challenge.
Clin Pharmacol Ther. 2012 Mar;91(3):418-25. doi: 10.1038/clpt.2011.321. Epub 2012 Feb 8.
3
Re-engineering drug discovery and development.
LDI Issue Brief. 2011 Oct;17(2):1-4.
4
Europe's innovation hub finally KICs off.
Nature. 2011 Feb 24;470(7335):450. doi: 10.1038/470450a.
5
[Laqueur and organon: the university laboratory and the pharmaceutical industry in the Netherlands].
Tijdschr Geschied Geneeskd Natuurwet Wiskd Tech. 1999;22(1):12-22.
6
Clarifying knowledge ownership in Europe's medicines initiative.
Nature. 2010 Aug 26;466(7310):1040-1. doi: 10.1038/4661040e.
7
Partners in discovery.
Nature. 2018 Mar 22;555(7697):S60. doi: 10.1038/d41586-018-02897-z.
8
[Cohorts and registers: Which public/private partnerships to choose?].
Presse Med. 2012 May;41 Suppl 1:S15-9. doi: 10.1016/j.lpm.2012.02.023. Epub 2012 Mar 30.
9
Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
Yale J Health Policy Law Ethics. 2008 Winter;8(1):1-36.
10
Drug discovery: new models for industry-academic partnerships.
Drug Discov Today. 2009 Jan;14(1-2):95-101. doi: 10.1016/j.drudis.2008.10.003. Epub 2008 Nov 21.
引用本文的文献
1
New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing.
Antimicrob Agents Chemother. 2013 Feb;57(2):996-1005. doi: 10.1128/AAC.01952-12. Epub 2012 Dec 17.
Zotero 插件